Steve Oh PhD

Prof. Steve Oh is the Director of Stem Cell Bioprocessing and Institute Professor/Scientist of the Bioprocessing Technology Institute (BTI) and an expert in integrated stem cell bioprocessing for the manufacture of human pluripotent/embryonic and adult mesenchymal stem cells for cell therapies. Key recent achievements include high density production of pluripotent stem cells, cardiomyocytes, neuroprogenitors and more recently red blood cells in suspension bioreactors. In the mesenchymal stem cell (MSC) area, methods of producing high quality MSCs, and primed towards cartilage and bone repair have been achieved. Recently a new assay for stem cell senescence useful for the quality control of stem cells for bioprocesses has been developed by his team. He has over 95 publications and 25 patents in stem cells production.